What is LOPJLB’s current signal on AGEN?

LOPJLB’s latest quantitative signal on Agenus Inc. (AGEN) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is AGEN in?

Agenus Inc. (AGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.

Agenus Inc. (AGEN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$7.43-3.13%Close

SELLCRISIS · day 5

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $309M
Beta: 1.55
P/E (TTM): 2.76

Short % float: 18.33%
Days to cover: 5.7
SI change: +0.2%

1W: -14.89%
1M: +7.06%

vs SPY 1W: -15.31%
vs SPY 1M: +5.00%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to…

Employees: 81
Headquarters: US
Founded: 2000
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 41.6M
Float: 89.3%

agenusbio.com ↗

Key executives

Jennifer S. Buell — Director and President & Chief Executive Officer of MiNK Therapeutics

Garo H. Armen — Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman

Steven J. O'Day — Chief Medical Officer

SEC filings

EDGAR · CIK 10989720 · AGEN

Analyst consensus

Buy

Bullish1083.3%

Neutral216.7%

Bearish00.0%

L $25.00Avg $25.00H $25.00

Target$25.00+236.47%

Last$7.43

FAQ

What is LOPJLB’s current signal on AGEN?: LOPJLB’s latest quantitative signal on Agenus Inc. (AGEN) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is AGEN in?: Agenus Inc. (AGEN) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Agenus Inc. (AGEN) do?: Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies. Agenus is als…

Key stats

Prediction markets

Company news

FAQ